Hi King Farouk,
Good with Neulasta!
Here is a report about Dacogen (decitabine) after Vidaza (azacitidine) with an overall response rate of 28%. The drugs work in different ways though both are DNA hypomethylating - decrease methylgroups that silence tumor suppressing genes. I posted a very complicated article about the two drugs a few days ago at "News...".
http://informahealthcare.com/doi/abs...28190701882146
About 25% of patients without the 5q- chromosome aberration respond to Revlimid. I don't think your father's bone marrow can tolerate both Dacogen and Revlimid - both decrease all counts in many patients.
Kind regards
Birgitta-A